Cerevel is now part of AbbVie.

AbbVie is a global biopharmaceutical company committed to creating medicines and solutions that put impact first - for patients, communities and our world. We focus on core therapeutic areas where our proven expertise and bold thinking have the greatest potential to solve unmet needs: immunology, oncology, neuroscience, eye care, medical aesthetics and other specialty areas.

For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on RUclips for future updates.